107 related articles for article (PubMed ID: 32482636)
1. Prognosis of Patients with Colorectal Cancer with Diabetes According to Medication Adherence: A Population-Based Cohort Study.
Choe S; Lee J; Park JW; Jeong SY; Cho YM; Park BJ; Shin A
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1120-1127. PubMed ID: 32482636
[TBL] [Abstract][Full Text] [Related]
2. Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients.
Kim YY; Lee JS; Kang HJ; Park SM
Sci Rep; 2018 Aug; 8(1):12190. PubMed ID: 30111867
[TBL] [Abstract][Full Text] [Related]
3. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
Ye X; Qian C; Liu J; St Peter WL
Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
[TBL] [Abstract][Full Text] [Related]
4. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
5. Adherence to oral diabetes medications among users and nonusers of antipsychotic medication.
Desai PR; Adeyemi AO; Richards KM; Lawson KA
Psychiatr Serv; 2014 Feb; 65(2):215-20. PubMed ID: 24233254
[TBL] [Abstract][Full Text] [Related]
6. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
[TBL] [Abstract][Full Text] [Related]
7. One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study.
Huber CA; Rapold R; Brüngger B; Reich O; Rosemann T
Medicine (Baltimore); 2016 Jun; 95(26):e3994. PubMed ID: 27368004
[TBL] [Abstract][Full Text] [Related]
8. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
[TBL] [Abstract][Full Text] [Related]
9. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
Zhang L; Zakharyan A; Stockl KM; Harada AS; Curtis BS; Solow BK
J Med Econ; 2011; 14(5):562-7. PubMed ID: 21728913
[TBL] [Abstract][Full Text] [Related]
10. Medication adherence and glycemic control among newly diagnosed diabetes patients.
Lin LK; Sun Y; Heng BH; Chew DEK; Chong PN
BMJ Open Diabetes Res Care; 2017; 5(1):e000429. PubMed ID: 28878942
[TBL] [Abstract][Full Text] [Related]
11. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
Feng JL; Qin X
Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
[TBL] [Abstract][Full Text] [Related]
12. Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas.
Bell KF; Cappell K; Liang M; Kong AM
Am Health Drug Benefits; 2017 Jun; 10(4):165-174. PubMed ID: 28794821
[TBL] [Abstract][Full Text] [Related]
13. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
14. Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design.
de Vries FM; Denig P; Vegter S; Bos HJ; Postma MJ; Hak E
Curr Med Res Opin; 2015 Apr; 31(4):595-602. PubMed ID: 25629791
[TBL] [Abstract][Full Text] [Related]
15. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
[TBL] [Abstract][Full Text] [Related]
16. Does adherence to lipid-lowering medications improve cancer survival? A nationwide study of breast and colorectal cancer, and melanoma.
Feng JL; Qin X
Br J Clin Pharmacol; 2021 Apr; 87(4):1847-1858. PubMed ID: 33084072
[TBL] [Abstract][Full Text] [Related]
17. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
18. Adherence of patients with type 2 diabetes mellitus to medications: the role of risk preferences.
Simon-Tuval T; Shmueli A; Harman-Boehm I
Curr Med Res Opin; 2018 Feb; 34(2):345-351. PubMed ID: 29069921
[TBL] [Abstract][Full Text] [Related]
19. Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register.
Hero C; Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Gudbjörnsdottir S; Andersson Sundell K; Eliasson B; Eeg-Olofsson K
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958300
[TBL] [Abstract][Full Text] [Related]
20. Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.
Simpson SH; Lin M; Eurich DT
Ann Pharmacother; 2016 Sep; 50(9):741-6. PubMed ID: 27307411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
